Table 2.

Recommended Schedule of Vaccinations for Adolescents Ages 11 to 12 Years

ImmunobiologicIndicationsNameDoseFrequencyRoute
Hepatitis A vaccineAdolescents who are at increased risk of hepatitis A infection or its complicationsHAVRIX*720 EL.U./0.5 mLA total of two doses at 0,§ 6–12 monthsIM
VAQTA*25 U/0.5 mLA total of two doses at 0, 6–18 monthsIM
Hepatitis B vaccineAdolescents not vaccinated previously for hepatitis BRecombivax HB*5 μg/0.5 mLA total of three doses at 0, 1–2, 4–6 monthsIM
Engerix-B*10 μg/0.5 mLA total of three doses at 0, 1–2, 4–6 monthsIM
Influenza vaccineAdolescents who are at increased risk for complications caused by influenza or who have contact with persons at increased risk for these complicationsInfluenza virus vaccine0.5 mLAnnually (September–December)IM
Measles, mumps, and rubella vaccine (MMR)Adolescents not vaccinated previously with two doses of measles vaccine at ≥12 months of ageMMR,*0.5 mLOne doseSC#
Pneumococcal polysaccharide vaccineAdolescents who are at increased risk for pneumococcal disease or its complicationsPneumococcal vaccine polyvalent0.5 mLOne doseIM or SC
Tetanus and diphtheria toxoids (Td)Adolescents not vaccinated within the previous 5 yearsTetanus and diphtheria toxoids, absorbed (for adult use)0.5 mLEvery 10 yearsIM
Varicella virus vaccineAdolescents not vaccinated and who have no reliable history of chickenpoxVARIVAX*0.5 mLOne dose**SC
  • * Manufacturer's product name.

  • Enzyme-linked immunosorbent assay (ELISA) unit.

  • Alternative dosage and schedule of 360 EL.U./0.5 mL and a total of three doses administered at 0, 1, and 6–12 months.

  • § 0 months represents timing of the initial dose, and subsequent numbers represent months after the initial dose.

  • Intramuscular injection.

  • Generic name.

  • # Subcutaneous injection.

  • ** Adolescents ≥13 years of age should be administered a total of two doses (0.5 mL/dose) subcutaneously at 0 and 4–8 weeks.